09/06/2024 7:02 PM | Apogee Therapeutics (Issuer) HENDERSON MICHAEL THOMAS (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/06/2024 7:03 PM | Apogee Therapeutics (Issuer) Dambkowski Carl (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/04/2024 12:35 PM | Apogee Therapeutics (Subject) HENDERSON MICHAEL THOMAS (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2024 7:05 PM | Apogee Therapeutics (Issuer) Henderson Jane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2024 6:29 AM | Apogee Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/12/2024 4:25 PM | Apogee Therapeutics (Filer)
| Form S-3ASR | |
08/12/2024 6:00 AM | Apogee Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
|
08/12/2024 5:35 AM | Apogee Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/09/2024 7:05 PM | Apogee Therapeutics (Issuer) HENDERSON MICHAEL THOMAS (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/09/2024 7:05 PM | Apogee Therapeutics (Issuer) Dambkowski Carl (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2024 12:18 PM | Apogee Therapeutics (Subject) HENDERSON MICHAEL THOMAS (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/05/2024 7:01 PM | Apogee Therapeutics (Issuer) Dambkowski Carl (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/05/2024 7:01 PM | Apogee Therapeutics (Issuer) HENDERSON MICHAEL THOMAS (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/05/2024 12:39 PM | Apogee Therapeutics (Subject) HENDERSON MICHAEL THOMAS (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2024 12:13 PM | Apogee Therapeutics (Subject) Dambkowski Carl (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2024 7:12 PM | Apogee Therapeutics (Issuer) JONES WILLIAM A JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 7:00 PM | Apogee Therapeutics (Issuer) Fairmount Funds Management LLC (Reporting) Harwin Peter Evan (Reporting) Kiselak Tomas (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 7:01 PM | Apogee Therapeutics (Issuer) Gottesdiener Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 7:02 PM | Apogee Therapeutics (Issuer) Shah Nimish P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 7:03 PM | Apogee Therapeutics (Issuer) Fox Jennifer A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 7:04 PM | Apogee Therapeutics (Issuer) Bollinger Lisa (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 7:05 PM | Apogee Therapeutics (Issuer) McKenna Mark C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 7:05 PM | Apogee Therapeutics (Issuer) Bollinger Lisa (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
05/30/2024 7:07 PM | Apogee Therapeutics (Issuer) Bollinger Lisa (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/28/2024 6:35 AM | Apogee Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/28/2024 6:36 AM | Apogee Therapeutics (Filer)
| Form DEFA14A | |
05/15/2024 3:39 PM | Apogee Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/13/2024 6:10 AM | Apogee Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/13/2024 6:26 AM | Apogee Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/13/2024 6:05 AM | Apogee Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/24/2024 3:15 PM | Apogee Therapeutics (Filer)
| Form DEF 14A | |
04/24/2024 3:16 PM | Apogee Therapeutics (Filer)
| Form DEFA14A | |
04/24/2024 3:18 PM | Apogee Therapeutics (Filer)
| Form ARS | |
04/01/2024 4:42 PM | Apogee Therapeutics (Subject) Fairmount Funds Management LLC (Filed by)
| Form SC 13D/A | |
04/01/2024 4:44 PM | Apogee Therapeutics (Issuer) Fairmount Funds Management LLC (Reporting) Fairmount Healthcare Fund II L.P. (Reporting) Fairmount Healthcare Fund L.P. (Reporting) Harwin Peter Evan (Reporting) Kiselak Tomas (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/25/2024 6:30 AM | Apogee Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/11/2024 5:01 AM | Apogee Therapeutics (Filer)
| Form 424B4 | |
03/07/2024 11:15 PM | Apogee Therapeutics (Filer)
| Form EFFECT | |
03/07/2024 5:27 PM | Apogee Therapeutics (Filer)
| Form S-1MEF | |
03/05/2024 7:15 AM | Apogee Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/05/2024 5:11 AM | Apogee Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Tim Sykes’ Urgent Trade Alert: “Make this move now” (Ad) WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock
This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9318&Placement=NativeDisplay&Source=NativeDisplay) Click here to see a unique election-year trade |
03/05/2024 5:15 AM | Apogee Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/14/2024 7:35 AM | Apogee Therapeutics (Subject) Deep Track Capital, LP (Filed by)
| Form SC 13G/A | |
02/09/2024 7:35 AM | Apogee Therapeutics (Subject) FMR LLC (Filed by)
| Form SC 13G/A | |
01/31/2024 3:30 PM | Apogee Therapeutics (Subject) Fairmount Funds Management LLC (Filed by)
| Form SC 13D/A | |
01/31/2024 3:31 PM | Apogee Therapeutics (Issuer) Fairmount Funds Management LLC (Reporting) Fairmount Healthcare Co-Invest II L.P. (Reporting) Fairmount Healthcare Fund II L.P. (Reporting) Fairmount Healthcare Fund L.P. (Reporting) Harwin Peter Evan (Reporting) Kiselak Tomas (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 7:00 PM | Apogee Therapeutics (Issuer) HENDERSON MICHAEL THOMAS (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 7:00 PM | Apogee Therapeutics (Issuer) Henderson Jane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 7:01 PM | Apogee Therapeutics (Issuer) Dambkowski Carl (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/13/2023 6:41 AM | Apogee Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2023 6:45 AM | Apogee Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |